.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Argus Health
AstraZeneca
Federal Trade Commission
Johnson and Johnson
Harvard Business School
Express Scripts
Fish and Richardson
Covington
Novartis

Generated: November 19, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: DEFERASIROX

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp
JADENU
deferasirox
TABLET;ORAL206910NDANovartis Pharmaceuticals Corporation0078-0654-1530 TABLET, FILM COATED in 1 BOTTLE (0078-0654-15)
Novartis Pharms Corp
JADENU
deferasirox
TABLET;ORAL206910NDANovartis Pharmaceuticals Corporation0078-0655-1530 TABLET, FILM COATED in 1 BOTTLE (0078-0655-15)
Novartis Pharms Corp
JADENU
deferasirox
TABLET;ORAL206910NDANovartis Pharmaceuticals Corporation0078-0656-1530 TABLET, FILM COATED in 1 BOTTLE (0078-0656-15)
Novartis Pharms Corp
JADENU SPRINKLE
deferasirox
GRANULE;ORAL207968NDANovartis Pharmaceuticals Corporation0078-0713-1530 PACKET in 1 CARTON (0078-0713-15) > 1 GRANULE in 1 PACKET (0078-0713-19)
Novartis Pharms Corp
JADENU SPRINKLE
deferasirox
GRANULE;ORAL207968NDANovartis Pharmaceuticals Corporation0078-0720-1530 PACKET in 1 CARTON (0078-0720-15) > 1 GRANULE in 1 PACKET (0078-0720-19)
Novartis Pharms Corp
JADENU SPRINKLE
deferasirox
GRANULE;ORAL207968NDANovartis Pharmaceuticals Corporation0078-0727-1530 PACKET in 1 CARTON (0078-0727-15) > 1 GRANULE in 1 PACKET (0078-0727-19)
Novartis
EXJADE
deferasirox
TABLET, FOR SUSPENSION;ORAL021882NDANovartis Pharmaceuticals Corporation0078-0468-1530 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0468-15)
Novartis
EXJADE
deferasirox
TABLET, FOR SUSPENSION;ORAL021882NDANovartis Pharmaceuticals Corporation0078-0469-1530 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)
Novartis
EXJADE
deferasirox
TABLET, FOR SUSPENSION;ORAL021882NDANovartis Pharmaceuticals Corporation0078-0470-1530 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0470-15)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Harvard Business School
Queensland Health
Farmers Insurance
Healthtrust
Johnson and Johnson
QuintilesIMS
Chubb
Daiichi Sankyo

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot